Global Type 2 Diabetes Mellitus Therapeutics Market Size, Status and Forecast 2022

April 2017 | 105 pages | ID: G85F68B1D1AEN
QYResearch

Abstracts

This report studies the global Type 2 Diabetes Mellitus Therapeutics market, analyzes and researches the Type 2 Diabetes Mellitus Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• AstraZeneca
• Novartis
• Novo Nordisk
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly
• Merck
• Sanofi
• Salix Pharmaceuticals
• Takeda Pharmaceutical Company Limited
• Ji’Nan Orgachem Pharmaceutical Co., Ltd.
• Shihuida PHARMA Group
• Henan Tian Fang Pharmaceutical Co., Ltd.
• Disha Pharmaceutical Group

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Type 2 Diabetes Mellitus Therapeutics can be split into

• Biguanides
• Insulin
• Thiazolidinediones
• Insulin Secretagogues
• Others

Market segment by Application, Type 2 Diabetes Mellitus Therapeutics can be split into

• Hospital
• Clinic
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Type 2 Diabetes Mellitus Therapeutics Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF TYPE 2 DIABETES MELLITUS THERAPEUTICS

1.1 Type 2 Diabetes Mellitus Therapeutics Market Overview
  1.1.1 Type 2 Diabetes Mellitus Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Type 2 Diabetes Mellitus Therapeutics Market by Type
  1.3.1 Biguanides
  1.3.2 Insulin
  1.3.3 Thiazolidinediones
  1.3.4 Insulin Secretagogues
  1.3.5 Others
1.4 Type 2 Diabetes Mellitus Therapeutics Market by End Users/Application
  1.4.1 Hospital
  1.4.2 Clinic
  1.4.3 Other

2 GLOBAL TYPE 2 DIABETES MELLITUS THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 AstraZeneca
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Novo Nordisk
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Boehringer Ingelheim
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Bristol-Myers Squibb
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Eli Lilly
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Merck
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Sanofi
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Salix Pharmaceuticals
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Takeda Pharmaceutical Company Limited
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Ji’Nan Orgachem Pharmaceutical Co., Ltd.
3.12 Shihuida PHARMA Group
3.13 Henan Tian Fang Pharmaceutical Co., Ltd.
3.14 Disha Pharmaceutical Group

4 GLOBAL TYPE 2 DIABETES MELLITUS THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Type (2012-2017)
4.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Type 2 Diabetes Mellitus Therapeutics in Future
4.4 Top Consumer/End Users of Type 2 Diabetes Mellitus Therapeutics

5 UNITED STATES TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
5.2 United States Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
6.2 EU Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 JAPAN TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
7.2 Japan Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 CHINA TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
8.2 China Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 INDIA TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
9.2 India Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA TYPE 2 DIABETES MELLITUS THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.2 EU Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.4 China Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.5 India Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Application (2017-2022)

12 TYPE 2 DIABETES MELLITUS THERAPEUTICS MARKET DYNAMICS

12.1 Type 2 Diabetes Mellitus Therapeutics Market Opportunities
12.2 Type 2 Diabetes Mellitus Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Type 2 Diabetes Mellitus Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Type 2 Diabetes Mellitus Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Type 2 Diabetes Mellitus Therapeutics Product Scope
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) (2012-2017)
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Regions in 2016
Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Type in 2016
Figure Biguanides Market Size (Million USD) and Growth Rate (2012-2017)
Figure Insulin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Thiazolidinediones Market Size (Million USD) and Growth Rate (2012-2017)
Figure Insulin Secretagogues Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Application in 2016
Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2012-2017)
Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2012-2017)
Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Salix Pharmaceuticals (2012-2017)
Figure Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical Company Limited (2012-2017)
Figure Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Ji’Nan Orgachem Pharmaceutical Co., Ltd. Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Ji’Nan Orgachem Pharmaceutical Co., Ltd. (2012-2017)
Figure Ji’Nan Orgachem Pharmaceutical Co., Ltd. Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Shihuida PHARMA Group Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Shihuida PHARMA Group (2012-2017)
Figure Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Henan Tian Fang Pharmaceutical Co., Ltd. Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Henan Tian Fang Pharmaceutical Co., Ltd. (2012-2017)
Figure Henan Tian Fang Pharmaceutical Co., Ltd. Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Disha Pharmaceutical Group Basic Information List
Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Disha Pharmaceutical Group (2012-2017)
Figure Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2012
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2013
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2014
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2015
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2016
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2017
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Type 2 Diabetes Mellitus Therapeutics
Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure China Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure India Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Regions in 2017
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Regions in 2022
Figure United States Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2017
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2022
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2022